ptrattler
Bluelighter
- Joined
- Oct 3, 2004
- Messages
- 64
Just received this from Endo this afternoon.
Title: Endo Pharmaceuticals Provides Regulatory Update on New Formulation of OPANA(R) ER Designed to be Crush-Resistant
Date(s): 7-Jan-2011 8:02 PM
For a complete listing of our news releases, please click here
It says the DFA requires no clinical studies to make this change. I guess that is what happened with Oxy.
It blows me away that they can make such a huge change such as the new OP and require no studies...
I have been on for 8+ yrs and boy do I notice the differance...Not the same drug in my opinion and that is not abusing them even..
Title: Endo Pharmaceuticals Provides Regulatory Update on New Formulation of OPANA(R) ER Designed to be Crush-Resistant
Date(s): 7-Jan-2011 8:02 PM
For a complete listing of our news releases, please click here
It says the DFA requires no clinical studies to make this change. I guess that is what happened with Oxy.
It blows me away that they can make such a huge change such as the new OP and require no studies...
I have been on for 8+ yrs and boy do I notice the differance...Not the same drug in my opinion and that is not abusing them even..
